Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Breast 1

Conditions

Anemia 30Neoplasms 16Lung Neoplasms 3Breast Neoplasms 3Carcinoma, Non-Small-Cell Lung 2Uterine Neoplasms 1Small Cell Lung Carcinoma 1Pleural Effusion, Malignant 1Pleural Effusion 1Ovarian Neoplasms 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Genital Neoplasms, Female 1Fatigue 1Carcinoma 1

Interventions

Dexamethasone 307Bortezomib 161Lenalidomide 130pomalidomide 112daratumumab 94carfilzomib 69Calcium Dobesilate 41Cyclophosphamide 40belantamab mafodotin 31elotuzumab 30fludarabine 27ixazomib 23isatuximab 21Melphalan 21venetoclax 18selinexor 17talquetamab 15Prednisone 15plerixafor 14Panobinostat 14Granulocyte Colony-Stimulating Factor 14Injections 12idecabtagene vicleucel 11Zoledronic Acid 11Thalidomide 11Azacitidine 11pembrolizumab 10tocilizumab 9nirogacestat 9liposomal doxorubicin 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Multiple Myeloma × Darbepoetin alfa × Clear all
NCT00036023 2009-05-11

Chemotherapy Related Anemia in Patients With Non-Myeloid Malignancies

Amgen

Phase 2 Completed
BreastLymphoidOther hematologic neoplasmPlasma cellThoracic

Breast Neoplasms, Lung Neoplasms, Lymphoma, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡